Ex vivo storage of human osteochondral allografts: Long-term analysis over 300 days using a Ringer-based solution

• Published in: Journal of orthopaedic research Vol. 42; no. 8; pp. 1719 - 1726
• Main Authors: Jiang, Zhida, Clausen, Jan-Dierk, Jahn, Denise, Wulsten, Dag, Gladitz, Luisa M, Bundkirchen, Katrin, Krettek, Christian, Neunaber, Claudia
• Format: Journal Article
• Language: English
• Published: United States 01.08.2024
• Subjects: Adult; Allografts; Bone Transplantation - methods; Cartilage, Articular - physiology; Chondrocytes - transplantation; Female; Glycosaminoglycans; Humans; Hydroxyproline; Isotonic Solutions; Male; Middle Aged; Organ Preservation Solutions; Ringer's Solution; osteochondral allograft; storage; graft preservation; cartilage; transplantation
• ISSN: 0736-0266; 1554-527X; 1554-527X
• DOI: 10.1002/jor.25821

Large osteochondral defects are a major challenge in orthopedics, for which osteochondral allograft (OCA) transplantation is nowadays considered as an option, especially in young patients. However, a major issue with OCA is the need for graft storage, which ensures adequate cartilage integrity over time. The aim of this study was to test how long a Ringer-based storage solution can provide good graft quality after explantation and thus meet the requirements for OCA. For this purpose, human osteochondral allografts of the knee and ankle were analyzed. Live/Dead analysis was performed and glycosaminoglycan, as well as hydroxyproline content, were measured as crucial chondrocyte integrity factors. Furthermore, biomechanical tests focusing on stress relaxation and elastic compression modulus were performed. The critical value of 70% living chondrocytes, which corresponds to a number of 300 cells/mm², was reached after an average of 16 weeks of storage. In addition, a constant cell shrinkage was observed over time. The amount of glycosaminoglycan and hydroxyroline showed a slight and constant decrease over time, but no significant differences when compared from Day 0 to the values at Weeks 40-43. Biomechanical testing also revealed no significant differences at the different time points. Therefore, the results show that the Ringer-based storage solution at 4°C is able to provide a chondrocyte survival of 70% until Week 16. This is comparable to previously published storage solutions. Therefore, the study contributes to the establishment of a Ringer-based osteochondral allograft transplantation system for countries where medium-based storage solution cannot be approved.